Finerenone and Atrial Fibrillation in Heart Failure: A Secondary Analysis of the FINEARTS-HF Randomized Clinical Trial.

Saved in:
Bibliographic Details
Title: Finerenone and Atrial Fibrillation in Heart Failure: A Secondary Analysis of the FINEARTS-HF Randomized Clinical Trial.
Authors: Matsumoto S; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.; Division of Cardiovascular Medicine, Department of Internal Medicine, Toho University Faculty of Medicine, Tokyo, Japan., Henderson AD; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom., Jhund PS; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom., Bauersachs J; Department of Cardiology and Angiology, Hannover Medical School, Hanover, Germany., Chioncel O; Emergency Institute for Cardiovascular Diseases 'Prof. Dr. C.C. Iliescu,' University of Medicine Carol Davila, Bucharest, Romania., Claggett BL; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Comin-Colet J; Department of Cardiology, Bellvitge University Hospital, and Bellvitge Biomedical Research Institute, Centro de Investigación Biomédica En Red Enfermedades Cardiovasculares, University of Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain., Desai AS; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Filippatos G; Department of Cardiology, Attikon University Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece., Lam CSP; National Heart Centre Singapore and Duke-National University of Singapore, Singapore, Singapore., Pitt B; Department of Medicine, University of Michigan School of Medicine, Ann Arbor., Scheerer MF; Medical Affairs & Pharmacovigilance, Pharmaceuticals, Bayer AG, Berlin, Germany., Lay-Flurrie J; Research & Development, Pharmaceuticals, Bayer plc, Reading, United Kingdom., Amarante F; Cardiology and Nephrology Clinical Development, Bayer SA, São Paulo, Brazil., Brinker M; Research & Development, Pharmaceuticals, Bayer AG, Wuppertal, Germany., Schou M; Department of Cardiology, Herlev-Gentofte University Hospital, Hellerup, Denmark., Senni M; Cardiovascular Department, University of Milano-Bicocca, Papa Giovanni XXIII Hospital, Bergamo, Italy., Shah SJ; Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois., Voors AA; Department of Cardiology, University of Groningen, Groningen, the Netherlands., Zannad F; Université de Lorraine, Inserm Clinical Investigation Center at Institut Lorrain du Coeur et des Vaisseaux, University Hospital of Nancy, Nancy, France., Zieroth S; Section of Cardiology, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada., Vaduganathan M; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., Solomon SD; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts., McMurray JJV; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.
Source: JAMA cardiology [JAMA Cardiol] 2025 Jul 01; Vol. 10 (7), pp. 696-707.
Publication Type: Journal Article; Randomized Controlled Trial; Multicenter Study
Journal Info: Publisher: American Medical Association Country of Publication: United States NLM ID: 101676033 Publication Model: Print Cited Medium: Internet ISSN: 2380-6591 (Electronic) NLM ISO Abbreviation: JAMA Cardiol Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 40156827
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: Finerenone and Atrial Fibrillation in Heart Failure: A Secondary Analysis of the FINEARTS-HF Randomized Clinical Trial.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Matsumoto+S%22">Matsumoto S</searchLink>; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.; Division of Cardiovascular Medicine, Department of Internal Medicine, Toho University Faculty of Medicine, Tokyo, Japan.<br /><searchLink fieldCode="AU" term="%22Henderson+AD%22">Henderson AD</searchLink>; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Jhund+PS%22">Jhund PS</searchLink>; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Bauersachs+J%22">Bauersachs J</searchLink>; Department of Cardiology and Angiology, Hannover Medical School, Hanover, Germany.<br /><searchLink fieldCode="AU" term="%22Chioncel+O%22">Chioncel O</searchLink>; Emergency Institute for Cardiovascular Diseases 'Prof. Dr. C.C. Iliescu,' University of Medicine Carol Davila, Bucharest, Romania.<br /><searchLink fieldCode="AU" term="%22Claggett+BL%22">Claggett BL</searchLink>; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Comin-Colet+J%22">Comin-Colet J</searchLink>; Department of Cardiology, Bellvitge University Hospital, and Bellvitge Biomedical Research Institute, Centro de Investigación Biomédica En Red Enfermedades Cardiovasculares, University of Barcelona, L'Hospitalet de Llobregat, Barcelona, Spain.<br /><searchLink fieldCode="AU" term="%22Desai+AS%22">Desai AS</searchLink>; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Filippatos+G%22">Filippatos G</searchLink>; Department of Cardiology, Attikon University Hospital, School of Medicine, National and Kapodistrian University of Athens, Athens, Greece.<br /><searchLink fieldCode="AU" term="%22Lam+CSP%22">Lam CSP</searchLink>; National Heart Centre Singapore and Duke-National University of Singapore, Singapore, Singapore.<br /><searchLink fieldCode="AU" term="%22Pitt+B%22">Pitt B</searchLink>; Department of Medicine, University of Michigan School of Medicine, Ann Arbor.<br /><searchLink fieldCode="AU" term="%22Scheerer+MF%22">Scheerer MF</searchLink>; Medical Affairs & Pharmacovigilance, Pharmaceuticals, Bayer AG, Berlin, Germany.<br /><searchLink fieldCode="AU" term="%22Lay-Flurrie+J%22">Lay-Flurrie J</searchLink>; Research & Development, Pharmaceuticals, Bayer plc, Reading, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Amarante+F%22">Amarante F</searchLink>; Cardiology and Nephrology Clinical Development, Bayer SA, São Paulo, Brazil.<br /><searchLink fieldCode="AU" term="%22Brinker+M%22">Brinker M</searchLink>; Research & Development, Pharmaceuticals, Bayer AG, Wuppertal, Germany.<br /><searchLink fieldCode="AU" term="%22Schou+M%22">Schou M</searchLink>; Department of Cardiology, Herlev-Gentofte University Hospital, Hellerup, Denmark.<br /><searchLink fieldCode="AU" term="%22Senni+M%22">Senni M</searchLink>; Cardiovascular Department, University of Milano-Bicocca, Papa Giovanni XXIII Hospital, Bergamo, Italy.<br /><searchLink fieldCode="AU" term="%22Shah+SJ%22">Shah SJ</searchLink>; Division of Cardiology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois.<br /><searchLink fieldCode="AU" term="%22Voors+AA%22">Voors AA</searchLink>; Department of Cardiology, University of Groningen, Groningen, the Netherlands.<br /><searchLink fieldCode="AU" term="%22Zannad+F%22">Zannad F</searchLink>; Université de Lorraine, Inserm Clinical Investigation Center at Institut Lorrain du Coeur et des Vaisseaux, University Hospital of Nancy, Nancy, France.<br /><searchLink fieldCode="AU" term="%22Zieroth+S%22">Zieroth S</searchLink>; Section of Cardiology, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada.<br /><searchLink fieldCode="AU" term="%22Vaduganathan+M%22">Vaduganathan M</searchLink>; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22Solomon+SD%22">Solomon SD</searchLink>; Cardiovascular Division, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.<br /><searchLink fieldCode="AU" term="%22McMurray+JJV%22">McMurray JJV</searchLink>; British Heart Foundation Cardiovascular Research Centre, University of Glasgow, Glasgow, United Kingdom.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101676033%22">JAMA cardiology</searchLink> [JAMA Cardiol] 2025 Jul 01; Vol. 10 (7), pp. 696-707.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article; Randomized Controlled Trial; Multicenter Study
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22American+Medical+Association%22">American Medical Association </searchLink><i>Country of Publication: </i>United States <i>NLM ID: </i>101676033 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>2380-6591 (Electronic) <i>NLM ISO Abbreviation: </i>JAMA Cardiol <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=40156827
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1001/jamacardio.2025.0848
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 696
    Titles:
      – TitleFull: Finerenone and Atrial Fibrillation in Heart Failure: A Secondary Analysis of the FINEARTS-HF Randomized Clinical Trial.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Matsumoto S
      – PersonEntity:
          Name:
            NameFull: Henderson AD
      – PersonEntity:
          Name:
            NameFull: Jhund PS
      – PersonEntity:
          Name:
            NameFull: Bauersachs J
      – PersonEntity:
          Name:
            NameFull: Chioncel O
      – PersonEntity:
          Name:
            NameFull: Claggett BL
      – PersonEntity:
          Name:
            NameFull: Comin-Colet J
      – PersonEntity:
          Name:
            NameFull: Desai AS
      – PersonEntity:
          Name:
            NameFull: Filippatos G
      – PersonEntity:
          Name:
            NameFull: Lam CSP
      – PersonEntity:
          Name:
            NameFull: Pitt B
      – PersonEntity:
          Name:
            NameFull: Scheerer MF
      – PersonEntity:
          Name:
            NameFull: Lay-Flurrie J
      – PersonEntity:
          Name:
            NameFull: Amarante F
      – PersonEntity:
          Name:
            NameFull: Brinker M
      – PersonEntity:
          Name:
            NameFull: Schou M
      – PersonEntity:
          Name:
            NameFull: Senni M
      – PersonEntity:
          Name:
            NameFull: Shah SJ
      – PersonEntity:
          Name:
            NameFull: Voors AA
      – PersonEntity:
          Name:
            NameFull: Zannad F
      – PersonEntity:
          Name:
            NameFull: Zieroth S
      – PersonEntity:
          Name:
            NameFull: Vaduganathan M
      – PersonEntity:
          Name:
            NameFull: Solomon SD
      – PersonEntity:
          Name:
            NameFull: McMurray JJV
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 07
              Text: 2025 Jul 01
              Type: published
              Y: 2025
          Identifiers:
            – Type: issn-electronic
              Value: 2380-6591
          Numbering:
            – Type: volume
              Value: 10
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: JAMA cardiology
              Type: main
ResultId 1